Metachronous

Metachronous is an adjective used in medicine to describe events that occur at different times. In oncology and related fields, it refers to lesions, tumors, or cancers that arise after the initial tumor has been diagnosed or treated, separated by a clinically meaningful interval. This contrasts with synchronous findings, which are present or diagnosed at roughly the same time.

Etymology: the term comes from Greek meta- meaning after or beyond, and chronos meaning time. It is used across medical specialties, including oncology, radiology, and pathology, to categorize the temporal sequence of disease manifestations.

In cancer care, metachronous events include metachronous primary tumors, where a patient develops a new, distinct primary cancer after a disease-free interval; and metachronous metastases, where metastatic lesions become detectable only after treatment of the original cancer. The distinction from synchronous disease is clinically relevant for prognosis and management, as metachronous events may indicate different biology or risk profiles and can influence surveillance strategies.

Timing thresholds vary; many sources use six months as a practical cut-off between synchronous and metachronous, but the exact interval depends on tumor type, treatment, and context. Examples include metachronous colorectal cancer after colectomy, or metachronous contralateral breast cancer following an initial breast cancer diagnosis.

In clinical practice, identifying metachronous disease guides follow-up scheduling and treatment planning.